GH Fragment 176-191 is a synthetic peptide derived from the C-terminal portion of human growth hormone (amino acids 176–191). Unlike full-length HGH, this fragment is designed to selectively stimulate lipolysis and inhibit lipogenesis, making it a subject of interest in metabolic, obesity, and fat-reduction research models.
Studies suggest that HGH Fragment 176-191 retains the fat-burning properties of native HGH while avoiding its impact on insulin sensitivity, IGF-1 levels, or muscle growth, allowing for more targeted metabolic investigations.
This compound is offered as a lyophilized powder in sterile, unlabeled glass vials to ensure purity and versatility in research settings. Our 10-vial research kits are produced under stringent quality control protocols and are independently batch-tested for identity and purity.
Each vial is intended for in vitro use only. Not for human consumption. Not for therapeutic or diagnostic purposes.
